OLAPARIB MAINTENANCE VS PLACEBO OR STANDARD OF CARE IN OVARIAN CANCER: A BIOMARKER-DRIVEN SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS
Farida NamozovaTashkent Medical Academy, Oncology, Tashkent, UzbekistanIsadora Mamede Mendes da SilvaFederal University of São João del-Re, Medical Department, Divinópolis, BrazilCarlos SteccaDivision of Medical Oncology, Medical Department, Abbotsford, CanadaCarolina FelippeUniversity of Rio Grande and Rio Grande Community College
2026en
Ochiq kirish: yoʻq
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba